Alerts will be sent to your verified email
Verify Email
FERMENTA
Insufficient data
Positive for this company
Neutral for this company
Negative for this company
Insufficient data to analyse
DIL Ltd offers research support services, manufactures enzymes and chemicals, provides entertainment, and develops levitation technology and wheelchairs. They excel in tailored solutions for efficient drug discovery, also involved in property, treasury & other activities.
Fermenta Biotech major competitors are Advanced Enzyme, Concord Biotech, Biocon, Bharat Parenterals, Wanbury, Anuh Pharma, Kwality Pharma.
Market Cap of Fermenta Biotech is ₹949 Crs.
While the median market cap of its peers are ₹1,028 Crs.
Fermenta Biotech seems to be less financially stable compared to its competitors.
Altman Z score of Fermenta Biotech is 4.24 and is ranked 5 out of its 8 competitors.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Annual Report | FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | ||
| Earnings Release | May Aug | Dec | Mar Jun | Sep | ||||||||||||||
| Investor Presentation | May Jun Aug | Mar Jun Sep Dec | Mar Jun Sep Dec | Feb Mar May Jun Aug Sep Dec | Mar Jun Sep Dec | Mar Jun Sep Dec | Mar Jun Dec | Jun Sep Dec | ||||||||||
| Conference Call | Mar | Mar Jun Sep Dec | Sep Dec | |||||||||||||||
|
Conference Call SummaryCon Call Summary
Powered by Gemini
|
